Key result
Initial admission to a major teaching hospital for AMI yielded no 30-day survival benefit versus nonteaching hospitals.
Why the study?
Does admission to a teaching hospital improve 30-day mortality in Medicare patients with acute myocardial infarction compared to nonteaching hospitals?
Observational (n=1,309,554)
Yes
Does admission to a teaching hospital improve 30-day mortality in Medicare patients with acute myocardial infarction compared to nonteaching hospitals?
Initial admission to a teaching hospital for acute myocardial infarction does not confer a significant survival benefit over nonteaching hospitals when appropriately accounting for patient transfers and severity.
Answers are grounded in this paper and cite their sources.
No 30-day AMI survival benefit at teaching hospitals; leaves open unmeasured confounding in observational comparisons.
PURPOSE: Previous studies have found that teaching hospitals produce better acute myocardial infarction (AMI) outcomes than nonteaching hospitals. However, these analyses generally excluded patients transferred out of nonteaching hospitals and did not study outcomes by patient risk level. The objective of this study was to determine whether admission to a teaching hospital was associated with greater survival after accounting for patient transfers and patient severity. METHOD: This observational study used logistic models to examine the association between hospital teaching status and 30-day mortality of AMI patients, adjusting for patient comorbidities and common time trends. The sample included 1,309,554 Medicare patients admitted from 1996 to 2004 to 3,761 acute care hospitals for AMI. The primary outcome was 30-day all-cause, all-location mortality. RESULTS: Mortality was slightly lower in minor teaching hospitals compared with nonteaching hospitals (odds ratio [OR] 0.97; 95% confidence interval [CI] 0.95-0.99) but not different between major teaching and nonteaching hospitals (OR 1.01; 95% CI 0.96-1.03). The odds of mortality in minor teaching hospitals decreased 4.2% relative to nonteaching hospitals during the seven-year period (OR from 0.98 to 0.94). There was no consistent pattern of association between teaching status and patient severity. CONCLUSIONS: After correctly accounting for the ability of nonteaching hospitals to appropriately transfer patients in need of different care, there was no survival benefit on average for initial admission to a teaching hospital for AMI. Further more, higher-risk patients did not benefit from initial admission to teaching hospitals.
No takes yet. Share an insight, caveat, or question.
Navathe et al. (2013) conducted an observational in Acute myocardial infarction (AMI) (n=1,309,554). Admission to a teaching hospital vs. Admission to a nonteaching hospital was evaluated on 30-day all-cause, all-location mortality (OR 1.01, 95% CI 0.96-1.03). Initial admission to a major teaching hospital for AMI yielded no 30-day survival benefit versus nonteaching hospitals.
Synapse has enriched 10 related papers. Consider them for comparative context: